Accreditation Information

Direct Accreditation:
Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Boston University School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Objectives

At the conclusion of this activity, participants will be able to

1. Discuss how recent research supports the use of oral antibiotic therapy for joint and or bone infections

2. Discuss the scenarios in which oral antibiotic therapy may be used instead of IV Antibiotic therapy

3. incorporate this knowledge into clinical practice

Target Audience

The target audience is diverse. One key audience is members of the Adult and Pediatric Infectious Disease Section, both clinicians and basic researchers. House staff, medical students and members of the Department of Microbiology are also regular participants.

Faculty Disclosure

Faculty, Planning Committee and CME Administrator disclosure statement

Alison Nelson, Speaker, has no relevant financial relationships to disclose

Sabrina Nagle, Co-course director, has no relevant financial relationships to disclose

Andrew Henderson, Co-course director, has no relevant financial relationships to disclose

Sakina Flint, RSS Coordinator, has no relevant financial relationships to disclose

 

 

Faculty Disclosure of off-label use

Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product

 

Faculty Disclosure Policy

Boston University School of Medicine asks all individuals, and their spouses/partners, involved in the development and presentation of Continuing Medical Education (CME) and Continuing Nursing Education (CNE) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed to CME activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to resolve all conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.